Chinese Community Inpatient Thromboembolism

Launched by RENJI HOSPITAL · Dec 4, 2023

Keywords

ClinConnect Summary

This clinical trial, called the Chinese Community Inpatient Thromboembolism study, is focused on understanding and preventing a condition known as venous thromboembolism (VTE), which can occur when blood clots form in the veins. The study will gather information from patients who are currently hospitalized in 20 community hospitals across China. Researchers will look at various factors like patients' age, medical history, medications, and lab results to assess their risk for developing VTE. They will also use special ultrasound tests to check for any existing blood clots and analyze blood samples to understand how well patients' blood is clotting.

To be eligible for this study, patients must be currently admitted to a community hospital and must agree to participate by signing a consent form. Unfortunately, outpatients and those who do not wish to participate will not be included. Participants can expect to be assessed for their risk of VTE and may help researchers develop a new risk scoring system specifically for community hospital patients. This research aims to improve the prevention and treatment of VTE, potentially benefiting future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Inpatients in community service centers
• • Patients or guardians agree with the study plan and sign the informed consent.
• Exclusion Criteria:
• • Outpatients in community service centers
• • The patient or guardian does not agree to sign the informed consent.